Acute Interstitial Nephritis Induced by Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP)-Unveiling a New Association: A Case Report. [PDF]
Vargas-Brochero MJ +4 more
europepmc +1 more source
A retrospective audit of the real-world safety and effectiveness profile of eptinezumab for treatment-resistant chronic migraine in Australia. [PDF]
Gunasekera L +7 more
europepmc +1 more source
Potential drug interaction between calcitonin gene-related peptide antagonists and neonatal Fc receptor inhibitors. [PDF]
Harlan A, Weber K.
europepmc +1 more source
Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine: A Retrospective, Observational Cohort Study. [PDF]
Lusk JB +9 more
europepmc +1 more source
Usefulness of the Support Video "Talking Picture Book" for Overcoming Hesitancy to Start Galcanezumab Therapy. [PDF]
Akiyama H, Yamano Y.
europepmc +1 more source
Monthly Headaches and Severity in Patients on Galcanezumab or Traditional Preventive Migraine Medication: A 24-Month Claims and Electronic Health Records Study. [PDF]
Varnado OJ +7 more
europepmc +1 more source
Health care resource utilization and direct costs incurred over 12 months by patients with migraine initiating self-injectable calcitonin gene-related peptide monoclonal antibodies: A US real-world study. [PDF]
Varnado OJ +5 more
europepmc +1 more source
Assessing the Occurrence of Hypertension in Patients Receiving Calcitonin Gene-Related Peptide Monoclonal Antibodies for Episodic and Chronic Migraine: A Systematic Review. [PDF]
Kakde SP +9 more
europepmc +1 more source
Effect of Biological Therapy on Symptom Burden and Functional Disability in Patients with Migraine: A Before-and-After Analysis. [PDF]
Ličina A +3 more
europepmc +1 more source
Multiple Sclerosis With Migraine and Pyoderma Gangrenosum Treated With Ofatumumab and Erenumab. [PDF]
Motegi H +4 more
europepmc +1 more source

